Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

Low blood sugar, or hypoglycemia, is common in people with type 1 diabetes. You can usually treat low blood sugar with the 15-15 rule: Consume 15 grams of carbohydrates and then wait 15 minutes to ...

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

In view of its prompt and sustained effectiveness, diazoxide currently appears to be the agent of choice in the pharmacologic treatment of chronic hypoglycemia in children as well as adults.

Majety recommended about 15 grams of fast-acting carbohydrates — like fruit juice or glucose tablets — because they can alleviate hypoglycemia quickly. “It is also important not to treat ...

[97–99] As part of the educational plan, the individual with diabetes and his or her domestic companions need to recognize the symptoms of hypoglycemia and be able to treat a hypoglycemic ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

Rezolute (RZLT) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, to ersodetug, RZ358, for the treatment of hypoglycemia due to ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH),which is expected to begin in 2H 2025Phase 1 ...

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

CHICAGO and ARLINGTON, Va. - The American Diabetes Association and a national supporter, Xeris Pharmaceuticals, have formed a multi-year strategic partnership to reinforce the importance of prescribin ...

Rezolute received Innovation Passport Designation from the U.K. Innovative License and Access Pathway (ILAP) Steering Group for ersodetug for the treatment of hypoglycemia due to congenital HI.